Buscar
Mostrando ítems 1-10 de 126
Hepatitis C Treatment Outcomes in Persons With HIV and Decompensated Cirrhosis Using a Collaborative Multidisciplinary HIV-Centered Approach
Fifty-four consecutive persons with HIV co-infected with hepatitis C virus (HCV) and liver decompensation were treated with direct-acting antivirals (DAA). The HCV treatment was delivered using a multidisciplinary ...
Correlation of Serum Cardiac Markers with Acute Decompensating Events in Liver Cirrhosis
(2020-01-01)
Background and Aim. Liver cirrhosis is often accompanied by insidious cardiac dysfunction. This retrospective cross-sectional study is aimed at exploring the correlation between serum cardiac markers and decompensating ...
Bariatric Surgery In Individuals With Liver Cirrhosis: A Narrative Review
(Associação Médica BrasileiraSão Paulo, 2017)
Immune dysfunction in cirrhosis: distinct cytokines phenotypes according to cirrhosis severity
(Elsevier, 2016-01)
BACKGROUND/OBJECTIVES: Cirrhosis associated immune dysfunction has been proposed to switch from a pro-inflammatory phenotype in stable cirrhosis to an immunodeficient one in patients with decompensated cirrhosis and ...
COVID-19 in a patient with liver cirrhosis
(2021-01-01)
Objective: Background: Case Report: Conclusions: Unusual clinical course The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), which manifests mainly as a respiratory condition, has become a global pandemic ...
Liver cancer and hepatic decompensation events in patients hospitalized with viral hepatitis in Spain
Background: Chronic viral hepatitis B, C, and D are the main causes of decompensated cirrhosis and liver cancer worldwide. Newborn HBV vaccination was implemented more than 2 decades ago in most EU countries. Furthermore, ...
Long-Term Treatment With Cisapride and Antibiotics in Liver Cirrhosis: Effect on Small Intestinal Motility, Bacterial Overgrowth, and Liver Function
(Elsevier, 2001)
OBJECTIVES: Altered small-bowel motility, lengthening of
the orocecal transit time, and small-intestinal bacterial overgrowth
have been described in patients with liver cirrhosis.
These changes might be related to the ...
Uso de albúmina a largo plazo en el paciente cirrótico. Revisión sistemática
(2023)
Cirrhosis is the final stage of chronic liver disease, has a high mortality and can be due to different etiologies. Albumin has three well-established indications: prevention of circulatory ysfunction induced by ...
Perfil e fatores associados à descompensação da cirrose em pacientes internados em um hospital terciário na região Sul do Brasil
(Universidade Federal de Santa MariaBrasilCiências da SaúdeUFSMPrograma de Pós-Graduação em Ciências da SaúdeCentro de Ciências da Saúde, 2020-10-28)
Liver cirrhosis is a highly prevalent disease, which develops in its natural history
complications that adds high morbidity and mortality. Progresses have been made to
better understand its pathophysiology and thereby ...
Trace Elements In Plasma And Nutritional Assessment In Patients With Compensated Cirrhosis On A Liver Transplant List
(Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia - IBEPEGE Colégio Brasileiro de Cirurgia Digestiva - CBCD Sociedade Brasileira de Motilidade Digestiva e Neurogastroenterologia - SBMDN Federação Brasileira de Gastroenterologia - FBGSociedade Brasileira de Hepatologia - SBHSociedade Brasileira de Endoscopia Digestiva - SOBED, 2016)